Unintentional weight loss beyond your GLP-1 goals
Empty calories, paused fat-burning, blood-sugar swings, stacked side effects, and looser food choices all add up
adult usage of weight-loss medications has more than doubled from 5.8% in early 2024 to 12.4% in 2Q/3Q 2025
Vomiting blood or dark material that looks like coffee grounds
Participants were randomized to placebo or retatrutide at 1 mg, 4 mg (dose-escalation), 4 mg (no escalation), 8 mg (escalation), 8 mg (no escalation), or 12 mg (escalation) for 48 weeks, following a slow titration protocol
Common symptoms include joint pain and stiffness throughout your body, constant fatigue, depression and anxiety, brain fog, tingling or numb hands or feet, digestive problems, and urinary incontinence